GETTEC

Groupe d'Etude des Tumeurs Tête et Cou
Unicancer

[GETTEC @GETTEC1]

Plus que 2 semaines avant la prochain conseil scientifique du GETTEC ! L’occasion de construire ensemble et d’accompagner les projets d’avenir, pour nos patients #RechercheClinique #Cancer #Tumeurs #TeteEtCou

[Pierre Blanchard, MD @PBlanchardMD]

Our latest meta-analysis on #chemoradiation in nasopharyngeal cancer out in @TheLancetOncol

Huge collaborative work.
✅ 28 trials, 8.000+ pts, 7.6y FU
✅ more chemo (ind+conc or conc+adj) ➡️superior (OS/PFS) to CRT alone but more tox

Free 50day link: https://t.co/BtRJDZERRZ

[GETTEC @GETTEC1]

"Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status https://t.co/MQsNxEg29Q

[GETTEC @GETTEC1]

Impact of HPV status in T1-2 oropharyngeal squamous cell carcinoma with bulky N3 nodes: a multicenter ⁦@GETTEC1⁩ study https://t.co/mbV5ddHXnY

[GETTEC @GETTEC1]

#Airway management in #TORS ? a French GETTEC survey of uses https://t.co/bLi3y3Haqk

[GETTEC @GETTEC1]

Symposium #marges GETTEC ⁦@GustaveRoussy⁩ introduction par le Pr Alexandre Bozec ⁦@Lacassagne_Nice⁩ ⁦

[GETTEC @GETTEC1]

Symposium GETTEC lors de la réunion nationale d’Intergroupe, 16 décembre 9h-12h: les #marges en cancerologie de la tête et du cou #hnscc #recherche https://t.co/SOsc8nOTGT

[GETTEC @GETTEC1]

Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC study https://t.co/9iLxA2JrIY

[Intergroupe ORL @IntergroupeORL]

Intergroupe ORL https://t.co/yj4b2nX59l
Appel à projets septembre 2021, c’est parti !
L’appel à projets est ouvert jusqu’au vendredi 27 août à minuit.
Prochaine session du Conseil Scientifique se déroulera le jeudi 09 septembre de 15h00 à 17h00.

[Intergroupe ORL @IntergroupeORL]

Coming in July, with 33 articles by renowned international authors knowledgeable in HN cancer management, IJPT Special Issue will be the definitive guide to the new standard of care: particle therapy in the magmt of HN malignancies.
Pr Juliette THARIAT is one of those authors !

[Florent Carsuzaa @FCarsuzaa]

Recommendations for radiotherapy in HNSCC in the presence of flaps @GETTEC1 @IntergroupeORL @H_N_C_I_G https://t.co/p6fLm15znP

[GETTEC @GETTEC1]

Point of view from French oncology research cooperative groups https://t.co/beTOnYKa0s

[AHNS @AHNSinfo]

https://t.co/07N77LICyX Development, translation, and preliminary validation of the neck dissection assessment tool

[GETTEC @GETTEC1]

Phase III #Salvage endoscopic #nasopharyngectomy versus IMRT #reirradiation #nasopharyngeal #carcinoma https://t.co/qWeXPbtfFf

[GETTEC @GETTEC1]

En cette journée mondiale contre le cancer, pour nos patients, pour tous, continuons à nous battre. Continuons la #recherche, sans relâche. #JourneeMondialeContreLeCancer
#LaRechercheAvance

[Gorphe Philippe @GorphePhilippe]

2021 International EHNS #Robotic Conference will be held on 2 & 3 of December, 2021, Paris, France #TORS #HNSCC
@EHNSnews @GETTEC1 @GustaveRoussy
Looking forward to welcoming you !

[Yungan TAO @YG_TAO]

Our paper of phase 2 trial GORTEC 2015-2 Debio1143-201 finally online, potential practice changing trial in locally advanced head and neck cancer @YPointreau
https://t.co/ZdniVvhXhb

[Intergroupe ORL @IntergroupeORL]

Prochaine réunion du GORTEC et de l'intergroupe ORL à Nantes les 3 et 4 décembre 2020
https://t.co/jkhxCOeBc1

[Intergroupe ORL @IntergroupeORL]

ERC Advanced Grant Call is open! Are you an established, leading principal investigator who wants long-term funding to pursue a ground-breaking, high-risk project? We have €492M for Europe-based projects run by researchers of any field/nationality

https://t.co/Qpt6jpDaPJ

[GETTEC @GETTEC1]

So much important ++

[JAMA @JAMA_current]

Mentorship is the cornerstone of academic medicine https://t.co/lsOZbonKct #medhum